EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Structural Advances in Respiratory Syncytial Virus: Implications for Vaccine and Antiviral Development

Xuanwei Huang, Caner Akıl iD, Peijun Zhang iD

Microorganisms · 16.05.2026 · 14 (5) · 1130

DOI: 10.3390/microorganisms14051130 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Microorganisms, online erschienen am 16.05.2026. Verfasst von Xuanwei Huang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Chinese Academy of Medical Sciences Oxford Institute, University of Oxford, Oxford OX3 7BN, UK. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 140 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, European Remanufacturing Council, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Respiratory syncytial virus (RSV) remains a leading cause of severe lower respiratory tract disease in infants, older adults, and immunocompromised individuals. Over the past decade, advances in structural biology, particularly cryo-electron microscopy (cryo-EM) and cryo-electron tomography (cryo-ET), have transformed our understanding of RSV architecture, dynamics, and the mechanisms of entry and replication. High-resolution structures of the prefusion F glycoprotein (pre-F) and its complexes with neutralizing antibodies established the rationale for structure-guided antigen stabilization and directly enabled the development of the first licensed RSV vaccines. Complementary structures of the ribonucleoprotein, polymerase complex, and matrix lattice have broadened therapeutic targets beyond F. Here, we summarize these structural advances; review current structure-guided vaccine, antibody, and antiviral development efforts; and highlight priorities for next-generation vaccines and therapeutics.

Schlagwörter

Stichwörter der Autor:innen

antibodiesantiviral strategiescryo-EMcryo-ETmembrane fusionrespiratory syncytial virusstructure-based vaccine design

Autor:innen und Institutionen

  • Chinese Academy of Medical Sciences Oxford Institute, University of Oxford, Oxford OX3 7BN, UK.
  • Division of Structural Biology, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK.
  • Diamond Light Source, Harwell Science and Innovation Campus, Didcot OX11 0DE, UK.

ORCID-Profile: Caner Akıl, Peijun Zhang

Förderung

  • Wellcome Trust
  • European Remanufacturing Council
  • National Institute of Allergy and Infectious Diseases
  • Chinese Academy of Medical Sciences & Peking Union Medical College
  • Nankai-Oxford Wenzhong Scholarship
  • Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Science
  • Wellcome Discovery Award
  • ERC AdG grant

Zitieren

APA

Huang, X., Akıl, C., & Zhang, P. (2026). Structural Advances in Respiratory Syncytial Virus: Implications for Vaccine and Antiviral Development. Microorganisms, 14(5), 1130. https://doi.org/10.3390/microorganisms14051130

Vancouver

Huang X, Akıl C, Zhang P. Structural Advances in Respiratory Syncytial Virus: Implications for Vaccine and Antiviral Development. Microorganisms. 2026;14(5):1130. doi:10.3390/microorganisms14051130

BibTeX
@article{Huang2026,
  author = {Huang, Xuanwei and Akıl, Caner and Zhang, Peijun},
  title = {Structural Advances in Respiratory Syncytial Virus: Implications for Vaccine and Antiviral Development},
  journal = {Microorganisms},
  year = {2026},
  volume = {14},
  number = {5},
  pages = {1130},
  doi = {10.3390/microorganisms14051130}
}
Kostenlos starten →